logo-loader

H₂0 Markets looks at AIM stocks

Published: 08:49 11 Oct 2012 BST

Michael Jarman, Chief Market Strategist at H₂0 Markets looks at the reasons why the AIM index has outperformed the FT100 year to date. Mike also says why he likes Medgenics (LON:MEDG), which he says is a long term play, and also the opportunity that presents itself at New World Oil & Gas (LON:NEW) after the company recently raised money.

HANetf founder and co-CEO discusses shift to active management in ETF market

HANetf founder and co-CEO Hector McNeil tells Proactive's Stephen Gunnion about shifting trends in the exchange-traded fund (ETF) market in the United States, indicating a big move towards active management within ETFs. Despite the European market lagging behind the US by three to five years,...

14 hours, 48 minutes ago